Filing Details

Accession Number:
0001127602-14-026646
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-27 17:32:20
Reporting Period:
2014-08-26
Filing Date:
2014-08-27
Accepted Time:
2014-08-27 17:32:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376545 G Gordon Pugh 852 Winter St.
Waltham MA 02451
Svp, Coo & Cro, Alkermes, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-08-26 4,794 $14.13 37,321 No 4 M Direct
Ordinary Shares Acquisiton 2014-08-26 11,206 $11.74 48,527 No 4 M Direct
Ordinary Shares Disposition 2014-08-26 16,000 $45.00 32,527 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2014-08-26 4,794 $0.00 4,794 $14.13
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2014-08-26 11,206 $0.00 11,206 $11.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-11-05 No 4 M Direct
11,594 2020-05-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 5,000 Indirect Gordon G. Pugh Revocable Trust - 2012
Ordinary Shares 15,000 Indirect Nancy E. Pugh Revocable Trust - 2012
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. These options are fully vested in accordance with their terms.